Dr. Carolyn Jacob, a board-certified dermatologist and founder of Chicago Cosmetic Surgery and Dermatology, oversaw the blinded evaluation. The study enrolled women aged 44 to 71 to compare the single-step serum against a combination of vitamin C, hyaluronic acid, and peptide treatments. By the end of the eight-week trial, the ARS-treated side demonstrated superior results in metrics ranging from radiance and skin roughness to overall appearance, tying only in the assessment of sagging.
One Serum Outperforms Three-Product Regimens in Clinical Study
A new split-face study reveals that Ourself’s Advanced Regenerative Serum outperforms a traditional three-product skincare regimen across six of seven aesthetic benchmarks. Conducted over eight weeks, the trial highlights a shift toward simplified routines, offering comparable skin barrier support while saving patients approximately $330 in retail costs.
The findings point to the efficacy of the company's patented Tiered-Release Vesicle (TRV) technology. This delivery system allows the serum to house bioactive peptides, dual-weight hyaluronic acid, vitamin C, and niacinamide in one formulation, mimicking the payload capacity of multiple products. Beyond clinical grading, participant feedback was unanimous: 100% of subjects found the streamlined approach easier to maintain, and 83% expressed a clear preference for the single-step regimen over the multi-product alternative.
Comments (0)
No comments yet. Be the first!